Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Powell

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
British Medical Journal|February 4, 1978
Thyroid disease and asthmaE D Powell
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|January 1, 1988
Peer counselling in the management of diabetes mellitusE D Powell
Canadian Family Physician Medecin De Famille Canadien|January 26, 2011
Illness and diabetesE D Powell
Toxicologic Pathology|January 1, 1991
Differences in the sensitivity of Fischer and Sprague-Dawley rats to aminoglycoside nephrotoxicityM K Reinhard, G H Hottendorf, E D Powell
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placeboM M Vickers, E D Powell, T R Asmis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Medical Journal|February 4, 1978
Thyroid disease and asthmaE D Powell
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|January 1, 1988
Peer counselling in the management of diabetes mellitusE D Powell
Canadian Family Physician Medecin De Famille Canadien|January 26, 2011
Illness and diabetesE D Powell
Toxicologic Pathology|January 1, 1991
Differences in the sensitivity of Fischer and Sprague-Dawley rats to aminoglycoside nephrotoxicityM K Reinhard, G H Hottendorf, E D Powell
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placeboM M Vickers, E D Powell, T R Asmis, et al.
Pageof 1